Intrarenal vascular effects of [des-Asp1] angiotensin I and angiotensin III in the dog. 1979

S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero

UI MeSH Term Description Entries
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
December 1975, Journal of medicinal chemistry,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
March 1979, The American journal of physiology,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
June 1983, Journal of hypertension,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
February 1978, The American journal of physiology,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
January 1982, Clinical and experimental pharmacology & physiology. Supplement,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
November 1994, Biological & pharmaceutical bulletin,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
May 1977, Circulation research,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
December 1975, The Journal of clinical endocrinology and metabolism,
S L Britton, and W H Beierwaltes, and M J Fiksen-Olsen, and J C Romero
February 1988, European journal of pharmacology,
Copied contents to your clipboard!